Spectral Medical (EDT) Stock Price, News & Analysis

Company Overview

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.

Key Stats

• Today's Range: C$1.37 to C$1.40
• 50-Day Range: C$1.32 to C$1.42
• 52-Week Range: C$1.05 to C$1.76
• Volume: 27,703 shs
• Average Volume: 53,238 shs
• Market Capitalization: C$404.92 million
• P/E Ratio: N/A
• Dividend Yield: 1.45%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: TSE:EDT
• Previous Symbol: TSE:SDI
• CIK: N/A
• Web: www.spectraldx.com
• Phone: +1-416-6263233
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$18.68 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -973.97%
• Return on Assets: -93.22%

Debt

• Debt-to-Equity Ratio: 26.03
• Current Ratio: 0.61
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: C$2.57 million
• Price / Sales: 157.62
• Cash Flow: C$0.02 per share
• Price / Cash Flow: 82.50
• Book Value: C($0.08) per share
• Price / Book: -17.25

Miscellaneous

• Outstanding Shares: 293,419,000
• Free Float: N/A
• Market Cap: C$404.92 million
• Optionable: Not Optionable
• Beta: 0.85